TY - JOUR
T1 - Paving the Way for Therapy
T2 - The Second International Conference of the Trisomy 21 Research Society
AU - Reeves, Roger H.
AU - Delabar, Jean
AU - Potier, Marie Claude
AU - Bhattacharyya, Anita
AU - Head, Elizabeth
AU - Lemere, Cynthia
AU - Dekker, Alain D.
AU - De Deyn, Peter
AU - Caviedes, Pablo
AU - Dierssen, Mara
AU - Busciglio, Jorge
N1 - Funding Information:
The 2nd International Conference of the Trisomy 21 Research Society was made possible by the generous support of Global Down Syndrome Foundation (presenting sponsors), the Jerome Lejeune Foundation, Lumind RDS-Foundation, the Matthews Foundation, Trisomie 21 France (main sponsors), the National Institutes of Health, NINDS, NCHD and NIA (R13 NS100380 to J.B.), the National Down Syndrome Society, Down Syndrome International, Alzheimer Association and Down Syndrome Association UK and robiodrug AG. T21RS is the first international nonprofit research society on Down syndrome, founded on the 17th of April 2014 in Groningen, the Netherlands. During the T21RS International Conference, the society also held its annual General Assembly meeting. Annual reports, conference material, and other information about the society can be found at http://www.t21rs. org.
Publisher Copyright:
© 2018 S. Karger AG, Basel.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - In the last decade, a number of important research advances in different fields have allowed Down syndrome (DS) research to flourish, creating a time of both unparalleled opportunity and considerable challenge. Building a scientific framework that distills mechanisms involved in the developmental intellectual disability of DS as well as the early-onset component of Alzheimer disease and the several other comorbidities associated with the condition is a challenge that scientists are now tackling using novel technologies and multidisciplinary approaches. The Trisomy 21 Research Society (T21RS) was founded in 2014 to address these evolving needs and challenges. In June of 2017, the T21RS held its 2nd International Conference in Chicago, USA. With more than 200 scientists, advocates, people with DS, and family members in attendance, the meeting served as a forum for the discussion of the latest research and clinical advances as well as the most compelling needs of people with DS and their families.
AB - In the last decade, a number of important research advances in different fields have allowed Down syndrome (DS) research to flourish, creating a time of both unparalleled opportunity and considerable challenge. Building a scientific framework that distills mechanisms involved in the developmental intellectual disability of DS as well as the early-onset component of Alzheimer disease and the several other comorbidities associated with the condition is a challenge that scientists are now tackling using novel technologies and multidisciplinary approaches. The Trisomy 21 Research Society (T21RS) was founded in 2014 to address these evolving needs and challenges. In June of 2017, the T21RS held its 2nd International Conference in Chicago, USA. With more than 200 scientists, advocates, people with DS, and family members in attendance, the meeting served as a forum for the discussion of the latest research and clinical advances as well as the most compelling needs of people with DS and their families.
UR - http://www.scopus.com/inward/record.url?scp=85056142799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056142799&partnerID=8YFLogxK
U2 - 10.1159/000494231
DO - 10.1159/000494231
M3 - Article
C2 - 30800043
AN - SCOPUS:85056142799
SN - 1661-8769
VL - 9
SP - 279
EP - 286
JO - Molecular Syndromology
JF - Molecular Syndromology
IS - 6
ER -